The influence of high glucose and high insulin on mechanisms controlling cell cycle progression and arrest in mouse C2C12 myoblasts: the comparison with IGF-I effect

J Endocrinol Invest. 2014 Mar;37(3):233-45. doi: 10.1007/s40618-013-0007-z. Epub 2014 Jan 9.

Abstract

Background: Myogenesis is susceptible to the availability of nutrients and humoral factors and suboptimal fetal environments affect the number of myofibers and muscle mass.

Aim: We examined the mechanisms regulating cell cycle progression and arrest in skeletal myoblasts.

Materials and methods: Mouse C2C12 myoblasts were subjected to proliferation or induction of differentiation in the presence of high glucose and high insulin (HGHI glucose 15 mmol/l, insulin 50 nmol/l), and these effects were compared with the influence of anabolic factor for skeletal muscle, insulin-like growth factor-I (IGF-I 30 nmol/l).

Results: High glucose and high insulin, similarly to IGF-I, increased the intracellular level of cyclin A, cyclin B1 and cyclin D1 during myoblast proliferation. In HGHI-treated myoblasts, these cyclins were localized mostly in the nuclei, and the level of cdk4-bound cyclin D1 was augmented. HGHI significantly stimulated the expression of cyclin D3, total level of p21 and cdk-bound fraction of p21 in differentiating cells. The cellular level of MyoD was augmented by HGHI both in proliferating and differentiating myogenic cells.

Conclusions: High glucose and insulin modify the mechanisms controlling cell cycle progression and the onset of myogenesis by: (1) increase of cyclin A, cyclin B1 and cyclin D1 in myoblast nuclei, and stimulation of cyclin D1-cdk4 binding; (2) increase in cyclin D3 and MyoD levels, and the p21-cdk4 complexes after induction of differentiation. Hyperglycemia/hyperinsulinemia during fetal or postnatal life could exert effects similar to IGF-I and can be, therefore, favourable for skeletal muscle growth and regeneration.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Blotting, Western
  • Cell Cycle / drug effects
  • Cell Cycle / physiology*
  • Cell Proliferation / drug effects
  • Cell Survival / drug effects
  • Cells, Cultured
  • Fluorescent Antibody Technique
  • Glucose / pharmacology*
  • Hypoglycemic Agents / pharmacology
  • Immunoprecipitation
  • Insulin / pharmacology*
  • Insulin-Like Growth Factor I / pharmacology*
  • Mice
  • Myoblasts / cytology*
  • Myoblasts / drug effects*
  • Myoblasts / metabolism
  • Sweetening Agents / pharmacology

Substances

  • Hypoglycemic Agents
  • Insulin
  • Sweetening Agents
  • Insulin-Like Growth Factor I
  • Glucose